A bill for an act relating to the production and administration of psilocybin and providing penalties.
Subcommittee Meeting: 01/26/2026 12:15PM RM 305 (Cancelled).
Summary
The bill creates a new chapter that defines who may grow, test, prescribe, and administer psilocybin for qualified patients, and sets up licensing, inventory tracking, and security requirements. It applies to producers, testing labs, qualified medical and therapy providers, and their agents. Penalties are added for activities that fall outside the authorized system.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when HF 2085 changes status, plus AI-powered summaries and stage predictions.
Sign up free